Search
for
Sort by
Research 691–720 of 1000+
- Hair loss in children: Common and uncommon causes; clinical and epidemiological study in Jordan
- Alopecia areata: A review
- Lupus panniculitis clinically simulating alopecia areata
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Helicobacter pylori infection and skin disorders
- Skin disease in pregnancy
- Topical Minoxidil
- Evaluation of hair loss
- Alopecia in Children: The Most Common Causes
- High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Trichoscopy - a useful tool in the preliminary differential diagnosis of autoimmune bullous diseases
- A study on dermatoses of pregnancy
- Frontal fibrosing alopecia and lichen planopilaris in HLA-identical mother and daughter
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- CUTANEOUS T-CELL LYMPHOMA
- Frontal fibrosing alopecia and genital Lichen sclerosus: Single‐center experience
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Dermatosis associated with menopause
- LETTERS TO THE EDITOR
- Photochemotherapy and Alopecia Areata
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Cancer risk by the subtype of alopecia
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus